Schedule 13D ownership disclosure
ESPERION THERAPEUTICS, INC.
Security class unavailable · CUSIP: 29664W105
Event date: 2017-12-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,957,894
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-17-000714
- Form type
- SC 13D
- Filer
- DOMAIN PARTERS VII L P
- CIK
- CIK 1374150
- Filed
- Dec 08, 2017
- Reporting period
- Dec 06, 2017
- Description
- Schedule 13D beneficial ownership